BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Serra AS, Eusébio D, Neves AR, Albuquerque T, Bhatt H, Biswas S, Costa D, Sousa Â. Synthesis and Characterization of Mannosylated Formulations to Deliver a Minicircle DNA Vaccine. Pharmaceutics 2021;13:673. [PMID: 34067176 DOI: 10.3390/pharmaceutics13050673] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Rajendran AP, Ogundana O, Morales LC, Meenakshi Sundaram DN, Kucharski C, Kc R, Uludağ H. Transfection Efficacy and Cellular Uptake of Lipid-Modified Polyethyleneimine Derivatives for Anionic Nanoparticles as Gene Delivery Vectors. ACS Appl Bio Mater 2023;6:1105-21. [PMID: 36853230 DOI: 10.1021/acsabm.2c00978] [Reference Citation Analysis]
2 Neves AR, Albuquerque T, Faria R, Gonçalves AM, Santos C, Vivès E, Boisguérin P, Passarinha LA, Sousa Â, Costa D. Development of WRAP5 Peptide Complexes for Targeted Drug/Gene Co-Delivery toward Glioblastoma Therapy. Pharmaceutics 2022;14:2213. [DOI: 10.3390/pharmaceutics14102213] [Reference Citation Analysis]
3 Uchida S. Delivery Systems of Plasmid DNA and Messenger RNA for Advanced Therapies. Pharmaceutics 2022;14:810. [DOI: 10.3390/pharmaceutics14040810] [Reference Citation Analysis]
4 Nunes R, Serra AS, Simaite A, Sousa Â. Modulation of Chitosan-TPP Nanoparticle Properties for Plasmid DNA Vaccines Delivery. Polymers (Basel) 2022;14. [PMID: 35406316 DOI: 10.3390/polym14071443] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Rodolfo C, Eusébio D, Ventura C, Nunes R, Florindo HF, Costa D, Sousa Â. Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System. Pharmaceutics 2021;13:1369. [PMID: 34575445 DOI: 10.3390/pharmaceutics13091369] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Zhang X, Cai A, Gao Y, Zhang Y, Duan X, Men K. Treatment of Melanoma by Nano-conjugate-Delivered Wee1 siRNA. Mol Pharm 2021. [PMID: 34375118 DOI: 10.1021/acs.molpharmaceut.1c00316] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]